Clinical Trials Browser

OTHER_GOV × Lymphoma, Non-Hodgkin × Rituximab × Clear all

NCT00280878 2016-01-15

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Non-Hodgkin